You are viewing: Canada Peritoneal Dialysis Market analysis
Part of: Peritoneal Dialysis Market (Global)

The Canada Peritoneal Dialysis Market was valued at $310 Million in 2026 and projected to reach to $413 Million by 2031, representing a compound annual growth rate of 5.9%. Canada's peritoneal dialysis market is positioned for steady growth through 2031, with a CAGR of 5.9% reflecting the country's aging demographic profile and rising chronic kidney disease prevalence.

Canada Peritoneal Dialysis Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Canada Peritoneal Dialysis Market Trends and Insights

  • This steady expansion reflects Canada's aging population, rising prevalence of end-stage renal disease, and increasing adoption of home-based dialysis therapies.
  • Canada's healthcare infrastructure and government reimbursement policies continue to support peritoneal dialysis as a cost-effective alternative to hemodialysis. The Canadian market benefits from strong clinical outcomes data and patient preference for peritoneal dialysis, which offers greater flexibility and improved quality of life compared to traditional in-center treatments.
  • Canada's investment in nephrology services and dialysis technology innovation further accelerates market penetration.
  • Between 2026 and 2031, Canada is expected to see increased demand driven by demographic shifts, improved patient awareness, and expanded access to peritoneal dialysis training programs across provinces..

Key Market Statistics

  • CAGR (2026-2031) 5.9% CAGR
  • Market Size, 2026 ~USD 310 Million
  • Forecast, 2031 ~USD 413 Million
  • Country Canada

Canada Peritoneal Dialysis Market Overview

Market Valuation Growth :

Canada's peritoneal dialysis market is valued at $310.0 million in 2026 and is projected to reach $413.0 million by 2031, demonstrating consistent market expansion driven by healthcare demand.

Aging Population Dynamics :

Canada's demographic shift toward an older population is significantly increasing the prevalence of end-stage renal disease, creating sustained demand for peritoneal dialysis solutions and home-based treatment options.

Home-Based Therapy Adoption :

Growing preference for home-based dialysis therapies in Canada reflects patient preference for independence and quality of life improvements, supported by robust healthcare infrastructure and clinical guidelines.

Government Reimbursement Support :

Canada's publicly funded healthcare system provides comprehensive reimbursement for peritoneal dialysis treatments, ensuring patient access and supporting market stability across provinces.

Canada Peritoneal Dialysis Market Dynamics

  • Provincial healthcare systems continue to prioritize home-based dialysis solutions as cost-effective alternatives to in-center hemodialysis, supported by strong clinical evidence and patient outcomes data. The market outlook remains positive as Canadian healthcare providers increasingly recognize peritoneal dialysis benefits for patient autonomy and quality of life.
  • Continued investment in renal care infrastructure, coupled with growing awareness among nephrologists and patients, will drive adoption rates.
  • Government reimbursement policies and integration with integrated care pathways will further support market expansion through 2031..

Market Ecosystem

logo-mobile

PERITONEAL DIALYSIS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
A global leader in kidney care offering a comprehensive peritoneal dialysis portfolio, including automated peritoneal dialysis (APD) cyclers, PD solutions, consumables, and digital therapy management platforms. The company supports home-based dialysis through extensive training, remote monitoring, and a strong global clinical network across North America, Europe, Asia Pacific, Latin America, and the Middle East. Improves treatment efficiency and patient independence through advanced APD technologies. Enhances therapy adherence, reduces infection risks with standardized protocols, and enables remote patient monitoring for better clinical outcomes and quality of life.
A dedicated kidney care company providing a broad portfolio of APD systems, CAPD solutions, PD cyclers, dialysis solutions, transfer sets, and digital renal care technologies. Vantive focuses on expanding access to home dialysis through connected care platforms, clinician education, and patient support programs across developed and emerging markets. Enables personalized home dialysis, improves treatment continuity, and enhances patient comfort. Connected care solutions support remote monitoring, optimize therapy adherence, and improve long-term clinical outcomes while reducing healthcare resource utilization.
Offers advanced PD access products including catheters, transfer sets, connectors, needles, and infection-prevention technologies used in peritoneal dialysis procedures. The company's products support safe catheter placement and standardized PD practices across hospitals and home-care settings. Minimizes catheter-related complications and peritonitis risk while improving procedural safety and reliability. Supports efficient PD initiation and maintenance, enhancing patient safety and reducing treatment interruptions.
Provides minimally invasive vascular access technologies, guidewires, introducers, catheters, and surgical products that facilitate safe placement and management of peritoneal dialysis catheters. The company leverages advanced medical device expertise to support renal access procedures worldwide. Enhances procedural success, improves catheter placement accuracy, and reduces access-related complications. Reliable device performance supports broader adoption of peritoneal dialysis and improves clinician confidence during implantation procedures.
One of the world's leading dialysis service providers offering comprehensive home-based peritoneal dialysis programs supported by patient education, clinical training, remote monitoring, and integrated kidney care services. DaVita emphasizes value-based care and multidisciplinary care coordination to expand PD adoption. Increases access to home-based dialysis, improves patient engagement and treatment adherence, and supports personalized care pathways. Integrated care models reduce hospitalization rates, improve long-term patient outcomes, and enhance overall healthcare cost efficiency.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • Canada's peritoneal dialysis market is valued at $310.0 million in 2026 and will reach $413.0 million by 2031, growing at 5.9% CAGR.
    • Canada's aging population and rising end-stage renal disease prevalence are primary drivers of market expansion through 2031.
    • Government reimbursement and home-based dialysis preference position Canada as a favorable market for peritoneal dialysis adoption.
    • Canada's investment in nephrology infrastructure and patient training programs will support sustained market growth between 2026 and 2031.

    Peritoneal Dialysis Market Report Scope

    Report Metric Details
    Base Year 2026
    Fastest Growing Segment PERITONEAL DIALYSIS MACHINES (Type)
    Forecast Period 2026-2031
    Growth Rate CAGR of 6% from 2026 to 2031
    Largest Segment PRODUCTS (Offering)
    Market Size Base Year (Billions) ~USD 10.58 (2026)
    Revenue Forecast (Billions) ~USD 14.16 (2031)
    Segments Covered Offering, Type, Modality, Disease Indication, End User

    Canada Peritoneal Dialysis Market Report Segmentation

    5 segment dimensions are covered across the global market.

    By Offering

    • Products
    • Services

    By Type

    • Other Peritoneal Dialysis Products
    • Peritoneal Dialysis Catheters
    • Peritoneal Dialysis Machines
    • Peritoneal Dialysis Solution Bags
    • Peritoneal Dialysis Transfer Sets

    By Modality

    • Automated Peritoneal Dialysis
    • Continuous Ambulatory Peritoneal Dialysis (Capd)

    By Disease Indication

    • Acute Kidney Injury
    • End-Stage Renal Disease
    • End-Stage Renal Diseases
    • Other Diseases

    By End User

    • Homecare
    • Hospitals & Independent Dialysis Centers
    • Other End Users

    Target Audience

    • Medical Device Manufacturers : Peritoneal dialysis equipment and supply manufacturers need Canada-specific market data to develop localized go-to-market strategies, assess market entry feasibility, and identify distribution partnerships.
    • Pharmaceutical Companies : Dialysate solution and medication developers require detailed Canadian market insights to understand reimbursement pathways, provincial formulary requirements, and clinical adoption drivers.
    • Healthcare Providers & Hospitals : Canadian nephrologists, dialysis centers, and hospital networks use market data to justify peritoneal dialysis program expansion, resource allocation, and patient care pathway optimization.
    • Investment & Private Equity Firms : Investors evaluating Canadian healthcare opportunities need accurate market sizing, growth projections, and competitive dynamics to assess investment returns in dialysis-related businesses.
    • Government & Policy Organizations : Provincial health ministries and healthcare policy bodies require market intelligence to inform renal care funding decisions, healthcare resource planning, and evidence-based policy development.

    Reasons to Buy this Report

    • Canada-Specific Market Sizing : Access precise valuation data for Canada's peritoneal dialysis market with detailed 2026-2031 forecasts, enabling accurate business planning and investment decisions tailored to the Canadian healthcare landscape.
    • Provincial Healthcare Insights : Understand Canada's unique provincial reimbursement structures, healthcare policies, and government funding mechanisms that directly impact market dynamics and commercial opportunities across regions.
    • Demographic & Clinical Trends : Leverage detailed analysis of Canada's aging population, ESRD prevalence rates, and home-based therapy adoption patterns to identify growth opportunities and patient segments.
    • Competitive Landscape Analysis : Gain insights into Canadian market competitors, product positioning, and distribution channels specific to the peritoneal dialysis sector for strategic market entry and expansion planning.
    • Regulatory & Reimbursement Framework : Understand Canada's regulatory requirements, Health Canada approvals, provincial formulary listings, and reimbursement policies essential for product commercialization and market success.

    Frequently asked questions

    What is the current size of Canada's peritoneal dialysis market?

    Canada's peritoneal dialysis market is valued at $310.0 million in 2026 and is expected to grow to $413.0 million by 2031.

    What is the projected growth rate for Canada's peritoneal dialysis market?

    Canada's peritoneal dialysis market is projected to grow at a compound annual growth rate of 5.9% from 2026 to 2031.

    What factors are driving growth in Canada's peritoneal dialysis market?

    Key drivers include Canada's aging population, rising prevalence of end-stage renal disease, government reimbursement support, and patient preference for home-based dialysis therapies.

    How does Canada's peritoneal dialysis market compare to other dialysis modalities?

    Peritoneal dialysis in Canada is increasingly preferred over hemodialysis due to greater flexibility, improved quality of life, and cost-effectiveness supported by Canada's healthcare system.

    What role does Canada's healthcare system play in peritoneal dialysis adoption?

    Canada's government reimbursement policies, provincial nephrology programs, and investment in dialysis training infrastructure actively support peritoneal dialysis adoption and market growth.

    RESEARCH METHODOLOGY

    The study involved major activities in estimating the current market size for the peritoneal dialysis market. Exhaustive secondary research was done to collect information on the Peritoneal dialysis market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the Peritoneal dialysis market.

    Secondary Research

    This research study involved the wide use of secondary sources, directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, Factiva, whitepapers, and companies’ house documents. Secondary research was undertaken to identify and collect information for this extensive, technical, market-oriented, and commercial study of the Peritoneal dialysis market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    In the primary research process, various supply- and demand-side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, VPs/Managing Directors, Marketing Heads/Directors, Sales Directors, Marketing/Sales Managers, Regional/Area Sales Managers, Export/Import Heads/Managers, and Other Peritoneal dialysis Market Related Personnel from various companies and organizations operating in the Peritoneal dialysis market. Primary sources from the demand side included Vice Presidents, C-level Executives, Department Heads, Enterprises, Individuals, Supply Management Team of Hospitals, Clinic Personnel, and Laboratory Technicians.

    Breakdown of Primary Interviews

    Peritoneal Dialysis Market Size, and Share

    Note 1: C-level primaries include CEOs, COOs, CTOs, and VPs.
    Note 2: Other primary roles include sales, marketing, and product management.
    Note 3: Companies are classified into tiers based on their total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the Peritoneal dialysis market. These methods were also used extensively to estimate the sizes of various market subsegments. The research methodology used to estimate the market size includes the following:

    Peritoneal Dialysis Market: Top-Down and Bottom-Up Approach

    Peritoneal Dialysis Market Top Down and Bottom Up Approach

    Data Triangulation

    The entire market was split into three segments when the market size was determined. Data triangulation and market breakdown were used as needed to complete the market engineering process and derive precise statistics for all segments.

    Approach for deriving the market size and estimating market growth.

    Using secondary data from paid and unpaid sources, the market rankings for the major players were determined through a thorough analysis of their Peritoneal dialysis sales. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.

    Market Definition

    Phototherapy involves the utilization of a specific wavelength of light for the treatment of various medical conditions (such as psoriasis, vitiligo, acne vulgaris, neonatal jaundice, cancer, and eczema) through exposure of the affected area of the body to a light source.

    Key Stakeholders

    • Peritoneal dialysis product manufacturers
    • Distributors, channel partners, and third-party suppliers
    • Peritoneal dialysis service providers
    • Dialysis research laboratories
    • Dialysis associations and organizations
    • Healthcare service providers (including hospitals and dialysis centers)
    • Dialysis nurses and nephrologists
    • Academic medical centers and universities
    • Business research and consulting service providers
    • Venture capitalists and other government funding organizations

    Report Objectives

    • To describe, analyze, and forecast the Peritoneal dialysis market, by offerings, modality, disease indication, end user, and region
    • To describe and forecast the Peritoneal dialysis market for key regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries
    • To provide detailed information regarding drivers, restraints, opportunities, and challenges influencing the growth of the Peritoneal dialysis market
    • To strategically analyze the ecosystem, regulations, patenting trend, value chain, Porter’s five forces, and prices pertaining to the market under study
    • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
    • To profile key players and comprehensively analyze their market shares and core competencies2 in the Peritoneal dialysis market
    • To analyze competitive developments such as collaborations, acquisitions, product launches, expansions, and R&D activities in the Peritoneal dialysis market

    Available customizations:

    With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:

    Product Analysis

    • Product matrix, which gives a detailed comparison of the product portfolios of each company

    Regional Analysis

    • Further breakdown of the Rest of Asia Pacific Peritoneal dialysis market into Vietnam, New Zealand, and others.
    • Further breakdown of the Rest of Latin America Peritoneal dialysis market into Colombia, Chile, Ecuador, and others.
    • Further breakdown of the Rest of Europe Peritoneal dialysis market into Belgium, Russia, the Netherlands, Switzerland, and others.

    Company Information

    • Detailed analysis and profiling of additional market players (up to 5)

    Get the Full Peritoneal Dialysis Market Report

    Full forecast, segment splits, and company analysis for all Peritoneal Dialysis Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status